Table 4.
Rorc+/+ Sham |
Rorc−/− Sham |
Rorc+/+ I/R (50 min) |
Rorc−/− I/R (50 min) |
Rorc−/− I/R (50 min) IL-17 |
|
---|---|---|---|---|---|
n | 6 | 5 | 6 | 6 | 5 |
pH | 7.38 ± 0.02 | 7.37 ± 0.02 | 7.37 ± 0.02 | 7.24 ± 0.04* | 7.37 ± 0.03† |
Na+, mmol/L | 139.2 ± 0.5 | 140.4 ± 1.1 | 143.3 ± 1.1 | 137.0 ± 2.3 | 141.0 ± 0.6 |
K+, mmol/L | 3.7 ± 0.1 | 3.5 ± 0.1 | 4.1 ± 0.2 | 5.0 ± 0.5* | 4.3 ± 0.3† |
Cl−, mmol/L | 108.5 ± 0.8 | 110.2 ± 1.9 | 110 ± 0.7 | 101.5 ± 2.0* | 106.0 ± 1.5† |
, mmol/L | 27.8 ± 1.0 | 27.5 ± 1.0 | 29.5 ± 0.7 | 21.6 ± 2.7* | 24.2 ± 2.8 |
Base deficit, mmol/L | 2.0 ± 1.0 | 1.4 ± 0.7 | 3.3 ± 0.7 | −6.0 ± 2.9* | 2.0 ± 1.3† |
Anion gap | 6.6 ± 0.5 | 6.2 ± 0.6 | 8.9 ± 0.6 | 18.9 ± 2.5* | 15.1 ± 3.7 |
Values are means ± SE. IL-17 was administered at a dose of 100 ng·kg−1·day−1 by an osmotic minipump. I/R, ischemia-reperfusion. Rorc, RAR-related orphan receptor C.
P < 0.05 Rorc−/− vs. Rorc+/+;
P < 0.05 Rorc−/− vehicle vs. Rorc−/− IL-17 treated, by one-way ANOVA and the Student–Newman–Keuls test.